AlphaFold predicted structure
GALC · P54803


Mean pLDDT
94.1/ 100
Very high
685 residues
Confidence breakdown
- Very high(≥ 90)91%
- Confident(70–90)3%
- Low(50–70)0%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
galactosylceramidase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Adult onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalAdult onset leukodystrophy
BIALLELIC, autosomal or pseudoautosomalChildhood onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomal+10 more panels — install the extension to see the full list inline on any page.
Krabbe disease
hereditary disease
inflammatory bowel disease
Crohn disease
spastic ataxia
Parkinson disease
adult Krabbe disease
late-infantile/juvenile Krabbe disease
infantile Krabbe disease
ulcerative colitis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Galactocerebrosidase
Hydrolyzes the galactose ester bonds of glycolipids such as galactosylceramide and galactosylsphingosine (PubMed:8281145, PubMed:8399327). Enzyme with very low activity responsible for the lysosomal catabolism of galactosylceramide, a major lipid in myelin, kidney and epithelial cells of small intestine and colon (PubMed:8281145, PubMed:8399327)
GALC · P54803


Mean pLDDT
94.1/ 100
Very high
685 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0